Bioinformatics for Cancer Immunotherapy

Area of Science:

• Immunology
• Bioinformatics
• Oncology

Background:

• The immune system recognizes foreign and cancer-specific antigens, including neoepitopes from somatic mutations.
• Neoepitopes presented by HLA molecules can be recognized by T cells, forming the basis for cancer immunotherapy.

Purpose of the Study:

• To provide an overview of the bioinformatics aspects in designing personalized neoantigen-based vaccines.
• To highlight the role of next-generation sequencing (NGS) and computational tools in this process.

Main Methods:

• Detection of individual cancer-specific tumor mutations using NGS.
• Prediction of potential neoepitopes from detected mutations.
• Bioinformatic analysis of T-cell receptor (TCR) sequencing for biomarker research.
• Quantification of immune cell infiltration in cancer samples.

Main Results:

• NGS and bioinformatics tools enable large-scale analysis for personalized vaccine design.
• Methods for mutation detection, neoepitope prediction, and TCR analysis are crucial.
• Quantifying immune cell infiltration aids in understanding treatment efficacy.

Conclusions:

• Personalized mutanome vaccines represent a customized immunotherapy approach.
• Bioinformatics is integral to the entire process, from mutation detection to vaccine design and biomarker analysis.
• This approach holds promise for effective cancer treatment by harnessing the patient's immune system.